Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
NCT ID: NCT01484158
Last Updated: 2015-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
450 participants
OBSERVATIONAL
2001-10-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
NCT06489080
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
NCT03984071
Mulltimodal Dynamic Risk Assessment Systems of Heart Failure in Patients With Myocardial Infarction.
NCT05760157
Assessment of the Diagnostic Performance of the Detection System and Establishment of an Intelligent and Rapid Triage Model
NCT06864676
Study on the Cardioprotection and Humoral Mechanism of Limb Ischemia Preconditioning
NCT01118000
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myocardial Infarction
Patients with myocardial infarction
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be treated within 12 hours after symptom onset
* Must be able to walk
* Must receive successful primary percutaneous coronary intervention
Exclusion Criteria
* Cerebrovascular disease with residual hemiplegia
* Severe peripheral arterial disease
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yokohama City University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasushi Matsuzawa
Primary Investigator
References
Explore related publications, articles, or registry entries linked to this study.
Matsuzawa Y, Konishi M, Akiyama E, Suzuki H, Nakayama N, Kiyokuni M, Sumita S, Ebina T, Kosuge M, Hibi K, Tsukahara K, Iwahashi N, Endo M, Maejima N, Saka K, Hashiba K, Okada K, Taguri M, Morita S, Sugiyama S, Ogawa H, Sashika H, Umemura S, Kimura K. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2013 May 14;61(19):1964-72. doi: 10.1016/j.jacc.2013.02.020. Epub 2013 Mar 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gait Speed Outcome Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.